Cargando…
Sphingolipids in neurodegenerative diseases
Neurodegenerative Diseases (NDDs) are a group of disorders that cause progressive deficits of neuronal function. Recent evidence argues that sphingolipid metabolism is affected in a surprisingly broad set of NDDs. These include some lysosomal storage diseases (LSDs), hereditary sensory and autonomou...
Autores principales: | Pan, Xueyang, Dutta, Debdeep, Lu, Shenzhao, Bellen, Hugo J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978793/ https://www.ncbi.nlm.nih.gov/pubmed/36875645 http://dx.doi.org/10.3389/fnins.2023.1137893 |
Ejemplares similares
-
Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals
por: Chen, Kuchuan, et al.
Publicado: (2016) -
Plasma sphingolipid abnormalities in neurodegenerative diseases
por: Oizumi, Hideki, et al.
Publicado: (2022) -
Neurodegenerative Disorders: Spotlight on Sphingolipids
por: Mandik, Frida, et al.
Publicado: (2021) -
Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases
por: Pujol-Lereis, Luciana M.
Publicado: (2019) -
Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration
por: Chen, Kuchuan, et al.
Publicado: (2016)